HER2+ 유방암

ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleThe First Affiliated Hospital w…Phase 2

Disitamb Vedotin ,pyrotinib (Disitamb Vedotin ,pyrotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

Docetaxel (Docetaxel, Docetaxel (T) + bevacizumab)

Breast Cancer · Breast Cancer

AntibodystaleHenan Cancer HospitalPhase 3

trastuzumab (Herceptin, Docetaxel+ carboplatin+ trastuzumab + patuzumab)

Breast Cancer,HER2-positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4

AntibodystaleCancer Trials IrelandPhase 2

trastuzumab (Herceptin, Docetaxel, Carboplatin and Trastuzumab)

Breast Cancer · Breast Cancer

AntibodystaleCancer Trials IrelandPhase 2

trastuzumab (Herceptin, Docetaxel, Carboplatin, Trastuzumab and Lapatinib)

Breast Cancer · Breast Cancer

AntibodystaleAuxilio Mutuo Cancer CenterPhase 2

trastuzumab (Herceptin, Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab)

Infiltrating Duct and Lobular Carcinoma In Situ; Invasive Lobular Breast Carcinoma · Infiltrating Duct and Lobular Carcinoma

#InfiltratingDuctandLobularCarcin#Antibody#Phase2#항체#면역항체+3

trastuzumab (Herceptin, TCH, Docetaxel, carboplatin, trastuzumab, Docetaxel, carboplatin, trastuzumab (TCH) + bevacizumab)

Breast Cancer · Breast Cancer

Docetaxel, doxorubicin, cyclophosphamide (TAC, Docetaxel, doxorubicin, cyclophosphamide, Docetaxel, doxorubicin, cyclophosphamide (TAC) + bevacizumab)

Breast Cancer · Breast Cancer

AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2

AntibodystaleAgendiaApproved

trastuzumab (Herceptin, Dose dense AC followed by T + trastuzumab + pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Approved#항체#면역항체+2

Doxorubicin and cyclophosphamide (AC, Doxorubicin and cyclophosphamide, Doxorubicin and cyclophosphamide (AC) + bevacizumab)

Breast Cancer · Breast Cancer

CGTBiologicstaleBeijing BiotechPhase 2

EB-DT-CAR-NK (Dual-target CAR-NK cells, Dual-target CAR-NK cells (EB-DT-CAR-NK))

Breast Cancer (Locally Advanced or Metastatic); HER2-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4

AntibodystaleKyoto Breast Cancer Research Ne…Phase 2

Durvalmab&Tremelimumab&Fulvestrant (Durvalmab&Tremelimumab&Fulvestrant)

Breast Cancer · Breast Cancer

AntibodystaleAstraZenecaPhase 2

임상시험 1상태 DISCONTINUED

durvalumab (Imfinzi, Durvalumab + Tremelimumab + metronomic Vinorelbine)

Advanced Solid Tumours; Breast Cancer · Advanced Solid Tumours

#AdvancedSolidTumours#Antibody#Phase2#항체#면역항체+3

AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab with Tremelimumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2

ADCBiologicstaleFudan UniversityPhase 2

E1: SHR-A1811 (E1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleFudan UniversityPhase 2

E2: SHR-A1811 with everolimus (E2: SHR-A1811 with everolimus)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleSecond Affiliated Hospital of G…Phase 1

EGFR/B7H3 CAR-T (EGFR/B7H3 CAR-T)

EGFR/ B7H3-positive Advanced Lung Cancer; EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3